Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV

被引:119
|
作者
Frank, DW
Vallis, A
Wiener-Kronish, JP
Roy-Burman, A
Spack, EG
Mullaney, BP
Megdoud, M
Marks, JD
Fritz, R
Sawa, T
机构
[1] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Anesthesia Res Lab, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pediat, Div Crit Care Med, San Francisco, CA 94143 USA
[5] Inter Mune, Brisbane, CA USA
[6] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2002年 / 186卷 / 01期
关键词
D O I
10.1086/341069
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pseudomonas aeruginosa is a gram-negative pathogen causing life-threatening infections. Lung injury and the development of sepsis depend largely on the expression of type III secretion system (TTSS) virulence. TTSS functions as a molecular syringe to deliver toxins directly to the cytosol of cells, inhibit innate immune mechanisms, and prevent bacterial clearance. Polyclonal antibodies that bind to PcrV of P. aeruginosa inhibit the delivery of type III toxins and enhance the clearance of bacteria during acute lung infections. PcrV is a homologue of LcrV, a protective antigen in the Yersinia TTSS and an integral component of TTSS. In this study, a murine monoclonal antibody (MAb) to PcrV was generated: MAb 166, which is protective against P. aeruginosa when coinstilled with the bacterial inoculum or intraperitoneally transferred to mice. Fab fragments from MAb 166 prevent sepsis and death. The epitope bound by MAb 166 was mapped to the carboxyl-terminus of PcrV.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 50 条
  • [1] Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa
    Sawa, Teiji
    Ito, Emi
    Vinh Huu Nguyen
    Haight, Matthew
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2843 - 2852
  • [2] Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis
    Caroline, Gebus
    Eric, Faudry
    Bohn, Yu-Sing Tammy
    Sylvie, Elsen
    Attree, Ina
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (35) : 23940 - 23949
  • [3] The effect of PcrV antibody to multidrug resistant pseudomonas aeruginosa induced cytoxicity
    Wang, Qin
    Li, Huayin
    Song, Yuanlin
    Bai, Chunxue
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis
    Long, Merete B.
    Gilmour, Amy
    Kehl, Margaret
    Tabor, David E.
    Keller, Ashley E.
    Warrener, Paul
    Gopalakrishnan, Vancheswaran
    Rosengren, Sanna
    Crichton, Megan L.
    McIntosh, Eve
    Giam, Yan Hui
    Keir, Holly R.
    Brailsford, Wayne
    Hughes, Rod
    Belvisi, Maria G.
    Sellman, Bret R.
    DiGiandomenico, Antonio
    Chalmers, James D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (01) : 35 - 46
  • [5] A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Bronchiectasis Patient Neutrophil-Mediated Killing of Pseudomonas Aeruginosa
    Long, M. B.
    Gilmour, A.
    Kehl, M.
    Tabor, D.
    Crichton, M. L.
    Lidwell, A. E.
    Lind, H.
    McIntosh, E.
    Giam, Y.
    Rosengren, S.
    Brailsford, W.
    Hughes, R.
    Digiandomenico, A.
    Chalmers, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] GENERATION AND CHARACTERIZATION OF MURINE ANTIFLAGELLUM MONOCLONAL-ANTIBODIES THAT ARE PROTECTIVE AGAINST LETHAL CHALLENGE WITH PSEUDOMONAS-AERUGINOSA
    ROSOK, MJ
    STEBBINS, MR
    CONNELLY, K
    LOSTROM, ME
    SIADAK, AW
    INFECTION AND IMMUNITY, 1990, 58 (12) : 3819 - 3828
  • [7] A monoclonal antibody specific for Pseudomonas aeruginosa amidase
    Novo, C
    Karmali, A
    Clemente, A
    Brown, PR
    HYBRIDOMA, 2001, 20 (04): : 273 - 279
  • [8] PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice
    Y. Song
    M. Baer
    R. Srinivasan
    J. Lima
    G. Yarranton
    C. Bebbington
    S. V. Lynch
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1837 - 1845
  • [9] The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia
    Naito, Yoshifumi
    Hamaoka, Saeko
    Kinoshita, Mao
    Kainuma, Atsushi
    Shimizu, Masaru
    Katoh, Hideya
    Moriyama, Kiyoshi
    Ishii, Ken J.
    Sawa, Teiji
    MICROBIOLOGY AND IMMUNOLOGY, 2018, 62 (12) : 774 - 785
  • [10] PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice
    Song, Y.
    Baer, M.
    Srinivasan, R.
    Lima, J.
    Yarranton, G.
    Bebbington, C.
    Lynch, S. V.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (08) : 1837 - 1845